Analysis of immune-related signatures of colorectal cancer identifying two different immune phenotypes: Evidence for immune checkpoint inhibitor therapy

Immune checkpoint inhibitor (ICI) therapy has revolutionized the treatment of numerous types of cancer, including colorectal cancer (CRC). Patients with CRC and deficient mismatch repair or high microsatellite instability could benefit from ICI treatment, although the response rate of most patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Gang, Wang, Lin, Diao, Tongwei, Chen, Ying, Cao, Chengbo, Zhang, Xindong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285802/
https://www.ncbi.nlm.nih.gov/pubmed/32565977
http://dx.doi.org/10.3892/ol.2020.11605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285802/
https://www.ncbi.nlm.nih.gov/pubmed/32565977
http://dx.doi.org/10.3892/ol.2020.11605

Ejemplares similares